CPG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo
被引:131
|
作者:
Segal, BM
论文数: 0引用数: 0
h-index: 0
机构:NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
Segal, BM
Chang, JT
论文数: 0引用数: 0
h-index: 0
机构:NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
Chang, JT
Shevach, EM
论文数: 0引用数: 0
h-index: 0
机构:NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
Shevach, EM
机构:
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] Howard Hughes Med Inst, Res Scholars Program, NIH, Bethesda, MD USA
来源:
JOURNAL OF IMMUNOLOGY
|
2000年
/
164卷
/
11期
关键词:
D O I:
10.4049/jimmunol.164.11.5683
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The mechanism of action of microbial adjuvants in promoting the differentiation of autoimmune effector cells remains to be elucidated. We demonstrate that CpG-containing oligodeoxynucleotides (ODN) can completely substitute for heat-killed mycobacteria in the priming of encephalitogenic myelin-reactive T cells in vivo. The adjuvanticity of the CpG ODN was secondary to their direct ability to induce IL-12 or to act synergistically with endogenous IL-12 to promote Th1 differentiation and encephalitogenicity. T cells primed in the absence of CpG with Ag and IFA alone appeared to be in a transitional state and had not undergone differentiation along a conventional Th pathway. Unlike Th2 cells, they expressed low levels of the IL-12R beta 2 subunit and retained the ability to differentiate into encephalitogenic effectors when reactivated in vitro under Th1-polarizing conditions. These results support the use of CpG ODN as adjuvants but also suggest that they could potentially trigger autoimmune disease in a susceptible individual.
机构:
Tekmira Pharmaceut Corp, Burnaby, BC, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Chikh, Ghania
de Jong, Susan D.
论文数: 0引用数: 0
h-index: 0
机构:Univ British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
de Jong, Susan D.
Sekirov, Laura
论文数: 0引用数: 0
h-index: 0
机构:
Tekmira Pharmaceut Corp, Burnaby, BC, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Sekirov, Laura
Raney, Sameersingh G.
论文数: 0引用数: 0
h-index: 0
机构:
Tekmira Pharmaceut Corp, Burnaby, BC, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Raney, Sameersingh G.
Kazem, Mikameh
论文数: 0引用数: 0
h-index: 0
机构:
Tekmira Pharmaceut Corp, Burnaby, BC, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Kazem, Mikameh
Wilson, Kaley D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Wilson, Kaley D.
Cullis, Pieter R.
论文数: 0引用数: 0
h-index: 0
机构:Univ British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Cullis, Pieter R.
Dutz, Jan P.
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Dermatol, Vancouver, BC V6T 1Z4, Canada
Univ British Columbia, Skin Sci & Children & Family Res Inst, Vancouver, BC V6T 1Z4, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada
Dutz, Jan P.
Tam, Ying K.
论文数: 0引用数: 0
h-index: 0
机构:
Tekmira Pharmaceut Corp, Burnaby, BC, CanadaUniv British Columbia, Ctr Drug Res & Dev, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada